Multiple sclerosis and glutamate excitotoxicity

Reviews in the Neurosciences

Volumn 24, Issue 1, 2013, Pages 71-88

  Kostic, Milos ^a   Zivkovic, Nikola ^a   Stojanovic, Ivana ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Axonal degeneration; Demyelination; Glutamate metabolizing enzymes; Glutamate receptors; Glutamate transporters

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPA RECEPTOR; ASPARTATE AMINOTRANSFERASE; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; EXCITATORY AMINO ACID TRANSPORTER 5; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMINO ACID BLOOD LEVEL; ARTICLE; EXCITOTOXICITY; HUMAN; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ANIMALS; CENTRAL NERVOUS SYSTEM; GLUTAMIC ACID; HUMANS; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; RECEPTORS, GLUTAMATE;

EID: 84877940219     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2012-0062     Document Type: Article

References (157)

1. Alberdi, E., Sanchez-Gomez, M.V., Marino, A., and Matute, C. (2002). Ca(2 +) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol. Dis. 9, 234-243. (Pubitemid 34261217)
2. Alberdi, E., Sanchez-Gomez, M.V., Torre, I., Domercq, M., Perez-Samartin, A., Perez-Cerda, F., and Matute, C. (2006). Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J. Neurosci. 26, 3220-3228.
3. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/ CED-3 protease nomenclature. Cell. 87, 171.
4. Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., and Nicotera, P. (1995). Glutamateinduced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15, 961-973.
5. Bannai, S. and Kitamura, E. (1980). Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255, 2372-2376. (Pubitemid 10036038)
6. Bannerman, P., Horiuchi, M., Feldman, D., Hahn, A., Itoh, A., See, J., Jia, Z.P., Itoh, T., and Pleasure, D. (2007). GluR2-free alpha-amino-3-hydroxy- 5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis. J. Neurochem. 102, 1064-1070. (Pubitemid 47174224)
7. Barnham, K.J., Masters, C.L., and Bush, A.I. (2004). Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214.
8. Beal, M.F. (1998). Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann. Neurol. 44(Suppl 1), S110-S114. (Pubitemid 28423836)
9. Besong, G., Battaglia, G., D'Onofrio, M., Di Marco, R., Ngomba, R.T., Storto, M., Castiglione, M., Mangano, K., Busceti, C.L., Nicoletti, F.R., et al. (2002). Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures. J. Neurosci. 22, 5403-5411. (Pubitemid 35386462)
10. Bezzi, P., Carmignoto, G., Pasti, L., Vesce, S., Rossi, D., Rizzini, B.L., Pozzan, T., and Volterra, A. (1998). Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281-285. (Pubitemid 28099014)
11. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001). CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710. (Pubitemid 32595408)
12. Bolton, C. and Paul, C. (1997). MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J. Pharmacol. Exp. Ther. 282, 397-402. (Pubitemid 27425567)
13. Brand-Schieber, E. and Werner, P. (2004). Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp. Neurol. 189, 5-9. (Pubitemid 39024449)
14. Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., and Nicoletti, F. (1994). Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur. J. Pharmacol. 256, 109-112. (Pubitemid 24117085)
15. Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., and Nicoletti, F. (1995). Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7, 1906-1913.
16. Bruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F., and Nicoletti, F. (1998). Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 18, 9594-9600. (Pubitemid 28543740)
17. Burdo, J., Dargusch, R., and Schubert, D. (2006). Distribution of the cystine/glutamate antiporter system xc-in the brain, kidney, and duodenum. J. Histochem. Cytochem. 54, 549-557.
18. Burnashev, N., Schoepfer, R., Monyer, H., Ruppersberg, J.P., Gunther, W., Seeburg, P.H., and Sakmann, B. (1992). Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257, 1415-1419.
19. Caner, H., Collins, J.L., Harris, S.M., Kassell, N.F., and Lee, K.S. (1993). Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607, 354-356. (Pubitemid 23104990)
20. Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E., and Lipton, S.A. (1992). Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12, 4427-4436.
21. Cho, Y. and Bannai, S. (1990). Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes. J. Neurochem. 55, 2091-2097. (Pubitemid 120021844)
22. Choi, D.W. (1992). Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
23. Christensen, J.K., Varming, T., Ahring, P.K., Jorgensen, T.D., and Nielsen, E. O . (2004). In vitro characterization of 5-carboxyl-2,4-di- benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J. Pharmacol. Exp. Ther. 309, 1003-1010. (Pubitemid 38678635)
24. Chung, R.S., McCormack, G.H., King, A.E., West, A.K., and Vickers, J.C. (2005). Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro. Exp. Neurol. 193, 481-488. (Pubitemid 40616195)
25. Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., and Caciagli, F. (1999). Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia. 27, 275-281. (Pubitemid 29413918)
26. Conn, P.J. and Pin, J.P. (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205-237. (Pubitemid 27238875)
27. Craner, M.J., Newcombe, J., Black, J.A., Hartle, C., Cuzner, M.L., and Waxman, S.G. (2004). Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na + /Ca2 + exchanger. Proc. Natl. Acad. Sci. USA 101, 8168-8173. (Pubitemid 38698072)
28. Daikhin, Y. and Yudkoff, M. (2000). Compartmentation of brain glutamate metabolism in neurons and glia. J. Nutr. 130(4S Suppl), S1026-S1031.
29. Danbolt, N.C. (2001). Glutamate uptake. Prog. Neurobiol. 65, 1-105. (Pubitemid 32479155)
30. Dargan, S.L., Clarke, V.R., Alushin, G.M., Sherwood, J.L., Nistico, R., Bortolotto, Z.A., Ogden, A.M., Bleakman, D., Doherty, A.J., Lodge, D., et al. (2009). ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology 56, 121-130.
31. Deng, W., Wang, H., Rosenberg, P.A., Volpe, J.J., and Jensen, F.E. (2004). Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl. Acad. Sci. USA 101, 7751-7756. (Pubitemid 38658101)
32. DeSilva, T.M., Kabakov, A.Y., Goldhoff, P.E., Volpe, J.J., and Rosenberg, P.A. (2009). Regulation of glutamate transport in developing rat oligodendrocytes. J. Neurosci. 29, 7898-7908.
33. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. (1999). The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61. (Pubitemid 29113865)
34. Domercq, M., Sanchez-Gomez, M.V., Areso, P., and Matute, C. (1999). Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur. J. Neurosci. 11, 2226-2236. (Pubitemid 29292316)
35. Domercq, M., Etxebarria, E., Perez-Samartin, A., and Matute, C. (2005). Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia. 52, 36-46. (Pubitemid 41532135)
36. Domercq, M., Sanchez-Gomez, M.V., Sherwin, C., Etxebarria, E., Fern, R., and Matute, C. (2007). System xc-and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J. Immunol. 178, 6549-6556. (Pubitemid 46717438)
37. D'Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R.T., Storto, M., Kingston, A.E., Orzi, F., De Blasi, A., Di Iorio, P., Nicoletti, F., et al. (2001). Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J. Neurochem. 78, 435-445. (Pubitemid 32729972)
38. Dugan, L.L., Sensi, S.L., Canzoniero, L.M., Handran, S.D., Rothman, S.M., Lin, T.S., Goldberg, M.P., and Choi, D.W. (1995). Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
39. Estrada Sanchez, A.M., Mejia-Toiber, J., and Massieu, L. (2008). Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch. Med. Res. 39, 265-276. (Pubitemid 351221151)
40. Fallarino, F., Volpi, C., Fazio, F., Notartomaso, S., Vacca, C., Busceti, C., Bicciato, S., Battaglia, G., Bruno, V., Puccetti, P., et al. (2010). Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat. Med. 16, 897-902.
41. Fazio, F., Notartomaso, S., Aronica, E., Storto, M., Battaglia, G., Vieira, E., Gatti, S., Bruno, V., Biagioni, F., Gradini, R., et al. (2008). Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis. Neuropharmacology 55, 491-499.
42. Ferreira, I.L., Duarte, C.B., and Carvalho, A.P. (1996). Ca2 + influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death. Eur. J. Pharmacol. 302, 153-162.
43. Ferrer, I., Lopez, E., Blanco, R., Rivera, R., Krupinski, J., and Marti, E. (2000). Differential c-Fos and caspase expression following kainic acid excitotoxicity. Acta Neuropathol. 99, 245-256. (Pubitemid 30099173)
44. Fressinaud, C., Weinrauder, H., Delaunoy, J.P., Tholey, G., Labourdette, G., and Sarlieve, L.L. (1991). Glutamine synthetase expression in rat oligodendrocytes in culture: regulation by hormones and growth factors. J. Cell Physiol. 149, 459-468. (Pubitemid 21910213)
45. Geurts, J.J., Wolswijk, G., Bo, L., van der Valk, P., Polman, C.H., Troost, D., and Aronica, E. (2003). Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 126, 1755-1766. (Pubitemid 36917335)
46. Geurts, J.J., Wolswijk, G., Bo, L., Redeker, S., Ramkema, M., Troost, D., and Aronica, E. (2005). Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J. Neuroimmunol. 158, 182-190. (Pubitemid 39626085)
47. Gilgun-Sherki, Y., Melamed, E., and Offen, D. (2004). The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251, 261-268. (Pubitemid 38387142)
48. Groom, A.J., Smith, T., and Turski, L. (2003). Multiple sclerosis and glutamate. Ann. NY Acad. Sci. 993, 229-275. (Pubitemid 36808454)
49. Gryder, D.S. and Rogawski, M.A. (2003). Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J. Neurosci. 23, 7069-7074. (Pubitemid 36975871)
50. Guo, F., Maeda, Y., Ko, E.M., Delgado, M., Horiuchi, M., Soulika, A., Miers, L., Burns, T., Itoh, T., Shen, H., et al. (2012). Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J. Neurosci. 32, 639-345.
51. Haglid, K.G., Wang, S., Qiner, Y., and Hamberger, A. (1994). Excitotoxicity. Experimental correlates to human epilepsy. Mol. Neurobiol. 9, 259-263.
52. Hara, M.R., Agrawal, N., Kim, S.F., Cascio, M.B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J.H., Tankou, S.K., Hester, L.D., et al. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell. Biol. 7, 665-674. (Pubitemid 40975747)
53. Hertz, L. (1979). Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Prog. Neurobiol. 13, 277-323. (Pubitemid 10239017)
54. Hollmann, M., Hartley, M., and Heinemann, S. (1991). Ca2 + permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853. (Pubitemid 121000528)
55. Huettner, J.E. (2003). Kainate receptors and synaptic transmission. Prog. Neurobiol. 70, 387-407. (Pubitemid 37159280)
56. Hynd, M.R., Scott, H.L., and Dodd, P.R. (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45, 583-595. (Pubitemid 38844879)
57. Itoh, T., Beesley, J., Itoh, A., Cohen, A.S., Kavanaugh, B., Coulter, D.A., Grinspan, J.B., and Pleasure, D. (2002). AMPA glutamate receptormediated calcium signaling is transiently enhanced during development of oligodendrocytes. J. Neurochem. 81, 390-402. (Pubitemid 34809364)
58. Kanunnikova, N.P. (2012). Role of brain glutamic acid metabolism changes in neurodegenerative pathologies. J. Biol. Earth. Sci. 2, M1-10
59. Karadottir, R., Cavelier, P., Bergersen, L.H., and Attwell, D. (2005). NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438, 1162-1166. (Pubitemid 41831686)
60. Korn, T., Magnus, T., and Jung, S. (2005). Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J. 19, 1878-1880. (Pubitemid 41598781)
61. Kornek, B., Storch, M.K., Bauer, J., Djamshidian, A., Weissert, R., Wallstroem, E., Stefferl, A., Zimprich, F., Olsson, T., Linington, C., et al. (2001). Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 124, 1114-1124. (Pubitemid 32510379)
62. Kukley, M., Capetillo-Zarate, E., and Dietrich, D. (2007). Vesicular glutamate release from axons in white matter. Nat. Neurosci. 10, 311-320.
63. Kurihara, T. and Tanabe, T. (2003). N-type Ca2 + channel. Nihon Yakurigaku Zasshi. 121, 211-222.
64. Kushnareva, Y.E., Wiley, S.E., Ward, M.W., Andreyev, A.Y., and Murphy, A.N. (2005). Excitotoxic injury to mitochondria isolated from cultured neurons. J. Biol. Chem. 280, 28894-28902. (Pubitemid 41161334)
65. Lankiewicz, S., Marc Luetjens, C., Truc Bui, N., Krohn, A.J., Poppe, M., Cole, G.M., Saido, T.C., and Prehn, J.H. (2000). Activation of calpain I converts excitotoxic neuron death into a caspaseindependent cell death. J. Biol. Chem. 275, 17064-17071. (Pubitemid 30398949)
66. Lerma, J. (2003). Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 4, 481-495. (Pubitemid 37280169)
67. LeVine, S.M. and Chakrabarty, A. (2004). The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1012, 252-266. (Pubitemid 38453530)
68. Lewerenz, J., Klein, M., and Methner, A. (2006). Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc-protects from oxidative glutamate toxicity. J. Neurochem. 98, 916-925. (Pubitemid 44051291)
69. Li, S., Mealing, G.A., Morley, P., and Stys, P.K. (1999). Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na +-dependent glutamate transport. J. Neurosci. 19, RC16.
70. Lipton, S.A. and Rosenberg, P.A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
71. Lohr, J., Knoechel, B., Caretto, D., and Abbas, A.K. (2009). Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes. Infect. 11, 589-593.
72. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707-717. (Pubitemid 30390191)
73. Luyt, K., Varadi, A., Durant, C.F., and Molnar, E. (2006). Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J. Neurochem. 99, 641-656. (Pubitemid 44477218)
74. Manji, H., Wills, A., Kitchen, N., Dorward, N., Connolly, S., and Mehta, A. (2009). Oxford Handbook of Neurology (New York, USA: Oxford University Press).
75. Mao, P. and Reddy, P.H. (2010). Is multiple sclerosis a mitochondrial disease? Biochim. Biophys. Acta 1802, 66-79.
76. Martinez-Hernandez, A., Bell, K.P., and Norenberg, M.D. (1977). Glutamine synthetase: glial localization in brain. Science 195, 1356-1358. (Pubitemid 8056735)
77. Matute, C. (1998). Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc. Natl. Acad. Sci. USA 95, 10229-10234. (Pubitemid 28415323)
78. Matute, C. and Ransom, B.R. (2012). Roles of white matter in central nervous system pathophysiologies. ASN Neuro. 4, pii: e00079.
79. Matute, C., Sanchez-Gomez, M.V., Martinez-Millan, L., and Miledi, R. (1997). Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA 94, 8830-8835. (Pubitemid 27335125)
80. Mayat, E., Petralia, R.S., Wang, Y.X., and Wenthold, R.J. (1995). Immunoprecipitation, immunoblotting, and immunocytochemistry studies suggest that glutamate receptor delta subunits form novel postsynaptic receptor complexes. J. Neurosci. 15, 2533-2546.
81. Mayer, M.L., Westbrook, G.L., and Guthrie, P.B. (1984). Voltagedependent block by Mg2 + of NMDA responses in spinal cord neurones. Nature 309, 261-263. (Pubitemid 14139936)
82. Miller, E., Mrowicka, M., Zolynski, K., and Kedziora, J. (2009). Oxidative stress in multiple sclerosis. Pol. Merkur. Lekarski. 27, 499-502.
83. Mitosek-Szewczyk, K., Sulkowski, G., Stelmasiak, Z., and Struzynska, L. (2008). Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 155, 45-52.
84. More, J.C., Nistico, R., Dolman, N.P., Clarke, V.R., Alt, A.J., Ogden, A.M., Buelens, F.P., Troop, H.M., Kelland, E.E., Pilato, F., et al. (2004). Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology 47, 46-64. (Pubitemid 38686310)
85. Murphy, C. and Newsholme, P. (1998). Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clin. Sci. 95, 397-407. (Pubitemid 28474725)
86. Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., and Coyle, J.T. (1989). Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2, 1547-1558.
87. Nelson, E.J., Connolly, J., and McArthur, P. (2003). Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism. Biol. Cell. 95, 3-8. (Pubitemid 36621831)
88. Newcombe, J., Uddin, A., Dove, R., Patel, B., Turski, L., Nishizawa, Y., and Smith, T. (2008). Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol. 18, 52-61.
89. Newsholme, E.A. and Calder, P.C. (1997). The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal. Nutrition 13, 728-730. (Pubitemid 27347181)
90. Nicholls, D.G. (2004). Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr. Mol. Med. 4, 149-177. (Pubitemid 38425912)
91. Nicholls, D.G. and Budd, S.L. (2000). Mitochondria and neuronal survival. Physiol. Rev. 80, 315-360. (Pubitemid 30060567)
92. Nimmrich, V., Szabo, R., Nyakas, C., Granic, I., Reymann, K.G., Schroder, U.H., Gross, G., Schoemaker, H., Wicke, K., Moller, A., et al. (2008). Inhibition of calpain prevents N-methyl-Daspartate-induced degeneration of the nucleus basalis and associated behavioral dysfunction. J. Pharmacol. Exp. Ther. 327, 343-352.
93. Obradovic, D., Kataranovski, M., Dincic, E., Obradovic, S., and Colic, M. (2012). Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis. Vojnosanit. Pregl. 69, 151-156.
94. Ohgoh, M., Hanada, T., Smith, T., Hashimoto, T., Ueno, M., Yamanishi, Y., Watanabe, M., and Nishizawa, Y. (2002). Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 125, 170-178. (Pubitemid 34327467)
95. Oka, A., Belliveau, M.J., Rosenberg, P.A., and Volpe, J.J. (1993). Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13, 1441-1453. (Pubitemid 23095389)
96. O'Kane, R.L., Martinez-Lopez, I., DeJoseph, M.R., Vina, J.R., and Hawkins, R.A. (1999). Na (+) -dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274, 31891-31895.
97. Olney, J.W. (1969). Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721.
98. Ouardouz, M., Malek, S., Coderre, E., and Stys, P.K. (2006). Complex interplay between glutamate receptors and intracellular Ca2 + stores during ischaemia in rat spinal cord white matter. J. Physiol. 577, 191-204. (Pubitemid 44698249)
99. Ouardouz, M., Coderre, E., Zamponi, G.W., Hameed, S., Yin, X., Trapp, B.D., and Stys, P.K. (2009a). Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 65, 160-166.
100. Ouardouz, M., Coderre, E., Basak, A., Chen, A., Zamponi, G.W., Hameed, S., Rehak, R., Yin, X., Trapp, B.D., and Stys, P.K. (2009b). Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 65, 151-159.
101. Pais, T.F., Figueiredo, C., Peixoto, R., Braz, M.H., and Chatterjee, S. (2008). Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflammation 5, 43.
102. Palmada, M. and Centelles, J.J. (1998). Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain. Front. Biosci. 3, 701-718.
103. Pampliega, O., Domercq, M., Soria, F.N., Villoslada, P., Rodriguez-Antiguedad, A., and Matute, C. (2011). Increased expression of cystine/glutamate antiporter in multiple sclerosis. J. Neuroinflammation 8, 63.
104. Pascual, O., Ben Achour, S., Rostaing, P., Triller, A., and Bessis, A. (2012). Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. USA 10, 197-205.
105. Pascuzzi, R.M., Shefner, J., Chappell, A.S., Bjerke, J.S., Tamura, R., Chaudhry, V., Clawson, L., Haas, L., and Rothstein, J.D. (2010). A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. 11, 266-271.
106. Paul, C. and Bolton, C. (2002). Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-Daspartate receptor antagonist memantine. J. Pharmacol. Exp. Ther. 302, 50-57. (Pubitemid 34680420)
107. Peghini, P., Janzen, J., and Stoffel, W. (1997). Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J. 16, 3822-3832. (Pubitemid 27280998)
108. Piani, D. and Fontana, A. (1994). Involvement of the cystine transport system xc-in the macrophage-induced glutamatedependent cytotoxicity to neurons. J. Immunol. 152, 3578-3585.
109. Piani, D., Frei, K., Do, K.Q., Cuenod, M., and Fontana, A. (1991). Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159-162.
110. Piani, D., Spranger, M., Frei, K., Schaffner, A., and Fontana, A. (1992). Macrophage-induced cytotoxicity of N-methyl-Daspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22, 2429-2436.
111. Pinteaux-Jones, F., Sevastou, I.G., Fry, V.A., Heales, S., Baker, D., and Pocock, J.M. (2008). Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J. Neurochem. 106, 442-454. (Pubitemid 351840229)
112. Pisani, A., Calabresi, P., Centonze, D., and Bernardi, G. (1997). Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Br. J. Pharmacol. 120, 1007-1014. (Pubitemid 27122637)
113. Pitt, D., Werner, P., and Raine, C.S. (2000). Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 67-70. (Pubitemid 30048528)
114. Pitt, D., Nagelmeier, I.E., Wilson, H.C., and Raine, C.S. (2003). Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis. Neurology 61, 1113-1120. (Pubitemid 37461947)
115. Prineas, J.W., Kwon, E.E., Cho, E.S., Sharer, L.R., Barnett, M.H., Oleszak, E.L., Hoffman, B., and Morgan, B.P. (2001). Immunopathology of secondary-progressive multiple sclerosis. Ann. Neurol. 50, 646-657. (Pubitemid 33021923)
116. Rego, A.C. and Oliveira, C.R. (2003). Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28, 1563-1574. (Pubitemid 37193539)
117. Rodrigues, R.J. and Lerma, J. (2012). Metabotropic signaling by kainate receptors. WIREs Membr. Transp. Signal. 1, 399-410.
118. Romagnani, S., Maggi, E., Liotta, F., Cosmi, L., and Annunziato, F. (2009). Properties and origin of human Th17 cells. Mol. Immunol. 47, 3-7.
119. Rothman, S.M. and Olney, J.W. (1968). Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19, 105-111.
120. Sarchielli, P., Greco, L., Floridi, A., Floridi, A., and Gallai, V. (2003). Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch. Neurol. 60, 1082-1088. (Pubitemid 36975795)
121. Sattler, R., Xiong, Z., Lu, W.Y., Hafner, M., MacDonald, J.F., and Tymianski, M. (1999). Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284, 1845-1848.
122. Schousboe, A. and Hertz, L. (1981). Role of astroglial cells in glutamate homeostasis. Adv. Biochem. Psychopharmacol. 27, 103-113.
123. Sharp, C.D., Hines, I., Houghton, J., Warren, A., Jackson, T.H., 4th, Jawahar, A., Nanda, A., Elrod, J.W., Long, A., Chi, A., et al. (2003). Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H2592-H2598. (Pubitemid 37443078)
124. Shaw, P.J. and Ince, P.G. (1997). Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 244(Suppl 2), S3-14. (Pubitemid 27208005)
125. Shijie, J., Takeuchi, H., Yawata, I., Harada, Y., Sonobe, Y., Doi, Y., Liang, J., Hua, L., Yasuoka, S., and Zhou, Y. (2009). Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. Tohoku. J. Exp. Med. 217, 87-92.
126. Siffrin, V., Radbruch, H., Glumm, R., Niesner, R., Paterka, M., Herz, J., Leuenberger, T., Lehmann, S.M., Luenstedt, S., Rinnenthal, J.L., et al. (2010). In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424-436.
127. Siman, R., Noszek, J.C., and Kegerise, C. (1989). Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9, 1579-1590. (Pubitemid 19146254)
128. Springer, J.E., Azbill, R.D., Hurd, R., Nelson, S., and Pelletier, D. (2000). Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci. 20, 7246-7251.
129. Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., and Pelletier, D. (2005). Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128, 1016-1025. (Pubitemid 40675457)
130. Sriram, S. and Rodriguez, M. (1997). Indictment of the microglia as the villain in multiple sclerosis. Neurology 48, 464-470. (Pubitemid 27087622)
131. Stadtman, E.R. (1992). Protein oxidation and aging. Science 257, 1220-1224.
132. Steinhauser, C. and Gallo, V. (1996). News on glutamate receptors in glial cells. Trends Neurosci. 19, 339-345. (Pubitemid 26349063)
133. Stout, A.K., Raphael, H.M., Kanterewicz, B.I., Klann, E., and Reynolds, I.J. (1998). Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1, 366-373.
134. Stover, J.F., Pleines, U.E., Morganti-Kossmann, M.C., Kossmann, T., Lowitzsch, K., and Kempski, O.S. (1997). Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur. J. Clin. Invest. 27, 1038-1043. (Pubitemid 28012626)
135. Stys, P.K., Waxman, S.G., and Ransom, B.R. (1992). Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na + channels and Na (+) -Ca2 + exchanger. J. Neurosci. 12, 430-439.
136. Sulkowski, G., Dabrowska-Bouta, B., Kwiatkowska-Patzer, B., and Struzynska, L. (2009). Alterations in glutamate transport and group I metabotropic glutamate receptors in the rat brain during acute phase of experimental autoimmune encephalomyelitis. Folia Neuropathol. 47, 329-337.
137. Szabo, C., Ischiropoulos, H., and Radi, R. (2007). Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662-680. (Pubitemid 47207751)
138. Takahashi, J.L., Giuliani, F., Power, C., Imai, Y., and Yong, V.W. (2003). Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 53, 588-595. (Pubitemid 36529432)
139. Takano, J., Tomioka, M., Tsubuki, S., Higuchi, M., Iwata, N., Itohara, S., Maki, M., and Saido, T.C. (2005). Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280, 16175-16184. (Pubitemid 40616744)
140. Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., and Suzumura, A. (2006). Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281, 21362-21368. (Pubitemid 44115475)
141. Tansey, F.A., Farooq, M., and Cammer, W. (1991). Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunocytochemical evidence. J. Neurochem. 56, 266-272. (Pubitemid 21901959)
142. Taylor, D.L., Diemel, L.T., Cuzner, M.L., and Pocock, J.M. (2002). Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J. Neurochem. 82, 1179-1191. (Pubitemid 34966630)
143. Taylor, D.L., Jones, F., Kubota, E.S., and Pocock, J.M. (2005). Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 25, 2952-2964. (Pubitemid 40389253)
144. Tenneti, L., D'Emilia, D.M., Troy, C.M., and Lipton, S.A. (1998). Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71, 946-959. (Pubitemid 28390249)
145. Tomioka, M., Shirotani, K., Iwata, N., Lee, H.J., Yang, F., Cole, G.M., Seyama, Y., and Saido, T.C. (2002). In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons. Brain Res. Mol. Brain Res. 108, 18-32. (Pubitemid 35447961)
146. Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Ogden, K.K., Hansen, K.B., Yuan, H., Myers, S.J., and Dingledine, R. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 62, 405-496.
147. Vallejo-Illarramendi, A., Domercq, M., Perez-Cerda, F., Ravid, R., and Matute, C. (2006). Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol. Dis. 21, 154-164. (Pubitemid 41817315)
148. Verkhratsky, A. and Steinhauser, C. (2000). Ion channels in glial cells. Brain Res. Rev. 32, 380-412. (Pubitemid 30171314)
149. Vesce, S., Rossi, D., Brambilla, L., and Volterra, A. (2007). Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int. Rev. Neurobiol. 82, 57-71.
150. Villoslada, P., Arrondo, G., Sepulcre, J., Alegre, M., and Artieda, J. (2009). Memantine induces reversible neurologic impairment in patients with MS. Neurology 72, 1630-1633.
151. Wallstrom, E., Diener, P., Ljungdahl, A., Khademi, M., Nilsson, C.G., and Olsson, T. (1996). Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J. Neurol. Sci. 137, 89-96. (Pubitemid 26172037)
152. Wang, J.Y., Chi, S.I., Wang, J.Y., Hwang, C.P., and Wang, J.Y. (1996). Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons. Chin. J. Physiol. 39, 227-233.
153. Werner, P., Pitt. D., and Raine. C.S. (2001). Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50, 169-180. (Pubitemid 32738141)
154. White, R.J. and Reynolds, I.J. (1995). Mitochondria and Na + /Ca2 + exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J. Neurosci. 15, 1318-1328.
155. Wong, R. (2006). NMDA receptors expressed in oligodendrocytes. Bioessays 28, 460-464. (Pubitemid 43668061)
156. Wu, H.Y., Tomizawa, K., Oda, Y., Wei, F.Y., Lu, Y.F., Matsushita, M., Li, S.T., Moriwaki, A., and Matsui, H. (2004). Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929-4940. (Pubitemid 38199089)
157. Yawata, I., Takeuchi, H., Doi, Y., Liang, J., Mizuno, T., and Suzumura, A. (2008). Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci. 82, 1111-1116.